Iressa Shows Promise For Treatment Of Metastatic Breast Cancer When Combined With Hormonal Therapy

Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical trial led by researchers.

Read the whole article on Science Daily

More from Science Daily